SCHEMBL8333355

SCHEMBL8333355

CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)Nc1nc2ccccc2s1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.77
LMNA P02545 5/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
TP53 P04637 3/20 0.57
ALOX15 P16050 2/20 0.57
TSHR P16473 2/20 0.57
NPSR1 Q6W5P4 2/20 0.57
USP2 O75604 1/20 0.57
HSD17B10 Q99714 1/20 0.57
NPC1 O15118 2/20 0.56
USP30 Q70CQ3 1/20 0.55
POLB P06746 3/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
MAPK1 P28482 2/20 0.55
MAPT P10636 1/20 0.55
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
ALOX12 P18054 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25938113 1.00 L3MBTL1 (0.77) L3MBTL1LMNASMN1; SMN2TP53ALOX15
SCHEMBL30557537 1.00 L3MBTL1 (0.77) L3MBTL1LMNASMN1; SMN2TP53ALOX15
SCHEMBL9892884 0.94 L3MBTL1 (0.68) L3MBTL1LMNASMN1; SMN2TP53ALOX15
SCHEMBL23418024 0.84 L3MBTL1 (0.67) L3MBTL1LMNASMN1; SMN2NPSR1NPC1
SCHEMBL3282254 0.84 L3MBTL1 (0.64) L3MBTL1LMNASMN1; SMN2NPSR1NPC1
SCHEMBL29919455 0.84 L3MBTL1 (0.67) L3MBTL1LMNASMN1; SMN2NPSR1NPC1
SCHEMBL25333202 0.84 SMN1; SMN2 (0.61) L3MBTL1LMNASMN1; SMN2TP53ALOX15
SCHEMBL13256799 0.84 L3MBTL1 (0.77) L3MBTL1LMNASMN1; SMN2TP53NPSR1
SCHEMBL16238648 0.84 L3MBTL1 (0.68) L3MBTL1LMNATP53ALOX15TSHR
SCHEMBL16238573 0.84 L3MBTL1 (0.68) L3MBTL1LMNASMN1; SMN2NPSR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023144793-A1 POL THETA INHIBITORS RHIZEN PHARMACEUTICALS AG (CH) 2023-08-03 WO disclosed
EP-0797447-A4 HUMAN CANCER INHIBITORY PENTAPEPTIDE HETEROCYCLIC AND HALOPHENYL AMIDES UNIV ARIZONA (US) 1999-09-29 EP disclosed
EP-0797447-A1 HUMAN CANCER INHIBITORY PENTAPEPTIDE HETEROCYCLIC AND HALOPHENYL AMIDES ARIZONA BOARD OF REGENTS (US) 1997-10-01 EP disclosed
US-5663149-A ANTICARCINOGENIC AGENTS RELATED TO DOLASTATIN ARIZONA BOARD OF REGENTS ACTING ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 1997-09-02 US disclosed
WO-1996018408-A1 HUMAN CANCER INHIBITORY PENTAPEPTIDE HETEROCYCLIC AND HALOPHENYL AMIDES ARIZONA BOARD OF REGENTS (US) 1996-06-20 WO disclosed